Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 8, 2022 | Post-IPO Equity | £122.50M | — | — | — | Detail |
Nov 8, 2021 | Post-IPO Equity | $250M | 1 | Blackstone Group | — | Detail |
Feb 10, 2021 | Post-IPO Equity | $100M | — | — | — | Detail |
Sep 17, 2019 | Post-IPO Equity | — | 1 | PPF Group | — | Detail |
Apr 11, 2019 | Post-IPO Equity | $100M | — | — | — | Detail |
Jun 22, 2018 | IPO | — | — | — | — | Detail |
Jan 1, 2018 | Post-IPO Equity | — | 1 | — | — | Detail |
Sep 26, 2017 | Series C | $80M | 7 | Cormorant Asset Management | — | Detail |
Mar 3, 2016 | Series B | £40M | 2 | Arix Bioscience , Woodford Investment Management | — | Detail |
Jan 22, 2015 | Series A | £30M | 1 | Syncona Partners LLP | — | Detail |